Haemonetics Corp reports results for the quarter ended in September - Earnings Summary

Haemonetics

09/11/2021 12:02

* Haemonetics Corp  HAE.N  reported quarterly adjusted earnings
of 60 cents​​ per share for the quarter ended in September. The
mean expectation of eight analysts for the quarter was
for earnings of 61 cents per share.
* Revenue rose 14.5% to $239.90 million from a year ago; 
analysts expected $241.41 million. 
* Haemonetics Corp's reported EPS for the quarter was 29 cents​.
* The mean earnings estimate of analysts had risen by about 0.2%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Haemonetics Corp shares had risen by 0.8% this quarter and
lost 40.1% so far this year.
* The company reported quarterly net income of $14.86 million.
* Wall Street's median 12-month price target for Haemonetics
Corp is $77.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 9 at 12:02 p.m.
 ​All figures in US dollars unless otherwise stated